University of Texas-Dallas: Grad's Business Acumen Helps Seal $52.5 Million Deal for Professors' Pain-Relief Startup
October 30, 2020
October 30, 2020
RICHARDSON, Texas, Oct. 30 (TNSMon) -- The University of Texas Dallas campus issued the following news release:
An alumnus of The University of Texas at Dallas proved to be the catalyst that two faculty members needed to successfully launch a biotech startup, CerSci Therapeutics, which was recently sold to a large pharmaceutical company for $52.5 million.
CerSci was founded in 2015 to develop therapies for pain relief without the addictive properties of opioids, which a . . .
An alumnus of The University of Texas at Dallas proved to be the catalyst that two faculty members needed to successfully launch a biotech startup, CerSci Therapeutics, which was recently sold to a large pharmaceutical company for $52.5 million.
CerSci was founded in 2015 to develop therapies for pain relief without the addictive properties of opioids, which a . . .